For instance, high expression of E3 ligase CRBN is reported in lung cancer, thus ligands for CRBN (lenidomide, thalidomide, pomalidomide) should be installed in the PROTAC model to develop an anti-lung cancer therapeutic. The gene discussed is CRBN; the disease is lung carcinoma.